Controlling ketosis in cows Flashcards
Background
- High herd and cow level prevalence
– Particularly in high producing dairy farms - Subclinical form of Type 2 ketosis most common
– Increased risk of clinical ketosis, RFM, LDA, metritis, lameness, mastitis, culling, death
Subclinical ketosis
- (newer terminology = hyperketonaemia)
- Blood BHB > 1.2mmol/L
- No clinical signs
Clinical ketosis
- Blood BHB > 3.0 mmol/L
- Clinical signs
Type 1 ketosis
- Occurs at peak lactation and related to failure to meet energy demands of milk production
- This occurs due to insufficient gluconeogenic pre-cursors (i.e. underfeeding)
Type 2 ketosis
- Occurs soon after calving and is associated with excessive fat mobilisation
- This is often associated with hepatic lipidosis
Type 3 ketosis
- (also called silage ketosis or butyric ketosis)
- Feeding of poor-quality butyric silage (carbohydrates are fermented to butyric acid rather than lactic acid) results in butyric acid being converted to BHB in the rumen.
Comparisons
- Ketosis in cattle is not the same as DKA (diabetic ketoacidosis) in small animals
- Ketosis in cattle is not called ketoacidosis
- Ketosis in cattle is not the same as acidosis (SARA or acute) in cattle
Prevention
- Preventing ketosis is key
Achieved through appropriate nutritional management
- Type 1 = management of nutrition during lactation to ensure demands are met
- Type 2 = management of nutrition in transition period to maximise DMI and minimise NEB
- Type 3 = management of silage to ensure adequate fermentation
- Pregnancy toxaemia = management of nutrition in late gestation
- Monensin
– questions re it’s use, but is beneficial
Prevention - why bother? (figures based on cows with subclinical ketosis
- 6x increased risk of displaced abomasum
- 4.5x increased risk of early cull
- 30% less likely to conceive to 1st service
- 2.2kg less milk per day in 1st 30 DIM
- For every 0.1 mmol/L increase in BHB
– 1.1x increased LDA risk
– 1.4x increased risk of cull
– 0.5kg/d less milk - Increased risk of developing clinical ketosis
- Increased risk of death
- Increased risk of progressing to hepatic lipidosis
- Pregnancy toxaemia
– High risk of death
– Increased risk of abortion - Subclinical disease should be treated when identified to prevent progression to more severe disease and development of associated co-morbidities
What is BHB?
- beta hydroxybutyrate
Why are cows at risk?
Energy requirements
- Maintenance ~ 10%bwt MJ ME/d
- Lactation ~ 5MJ ME/L
When are cows at risk?
- Just after calving yield is increasing much faster than food intake (type 2)
- In high yielding cows it can also be difficult to provide enough energy for peak lactation (Type1)
- particularly at risk around calving
- appetite drops cows in the late dry period, so day of calving feed intake drops
Pathophysiology - type I ketosis
= failure to meet peak lactation demand
- Reduction in production of glucose precursors in rumen
- Results in a reduction in hepatic glucose production
- Liver metabolises fatty acids -> ketones produced, also NEFAs are not taken up by hepatocytes
- Clinically this can be detected by elevated measurements of BHB and NEFA in blood and other fluids
Pathophysiology - type II ketosis and fatty liver
- Altered glucose metabolism results in negative effects on milk yield, reproductive performance and increases the risk of metabolic disorders
- Oxidation of NEFAs favours ketone bodies when blood glucose is low -> hyperketonaemia
- Large amount of NEFA exceed liver capacity for oxidisation and NEFAs starts to be esterified to TAG. Export is very slow in ruminants -> TAG accumulates in hepatocytes -> hepatic lipidosis
- NEFAs absorbed by liver and can be processed one of 2 ways:
– Oxidation -> ketone bodies or ATP
– Esterification -> triacylglyceride (once the concentrations are high it exceeds the livers capacity to oxidise them and they’re esterified) - In NEB NEFAs are released from adipose tissue
- End stage: liver failure
– due to so many triglycerides being accumulated, the hepatocytes don’t work
Pathophysiology - Hepatic lipidosis (fatty liver)
- Associated with type 2 ketosis
– Likely part of a spectrum - Circulating NEFAs exceed liver capacity for processing
– Re-esterified and deposited in hepatocytes as triacylglycerol (TAG)
(“liver lipid accumulation”)
– Larger deposits of TAG can interfere with hepatic function
– Exacerbates NEB - Can be fatal